,2 For example, BRCA1 and BRCA2 testing is offered to individuals with breast or ovarian cancer and/or a known history of hereditary breast and ovarian cancer (HBOC)3 in many countries, including the UK and USA, although there have been suggestions that this should be expanded to all women diagnosed with breast cancer.4 This evidence concerns the gene BRCA2 and breast cancer.